234 related articles for article (PubMed ID: 28457705)
1. Inhibition of Eukaryotic Translation by the Antitumor Natural Product Agelastatin A.
McClary B; Zinshteyn B; Meyer M; Jouanneau M; Pellegrino S; Yusupova G; Schuller A; Reyes JCP; Lu J; Guo Z; Ayinde S; Luo C; Dang Y; Romo D; Yusupov M; Green R; Liu JO
Cell Chem Biol; 2017 May; 24(5):605-613.e5. PubMed ID: 28457705
[TBL] [Abstract][Full Text] [Related]
2. Derivatization of agelastatin A leading to bioactive analogs and a trifunctional probe.
Jouanneau M; McClary B; Reyes JC; Chen R; Chen Y; Plunkett W; Cheng X; Milinichik AZ; Albone EF; Liu JO; Romo D
Bioorg Med Chem Lett; 2016 Apr; 26(8):2092-7. PubMed ID: 26951751
[TBL] [Abstract][Full Text] [Related]
3. Uncovering the Cellular Target of Agelastatin A.
Park Y; Liau BB
Cell Chem Biol; 2017 May; 24(5):542-543. PubMed ID: 28525767
[TBL] [Abstract][Full Text] [Related]
4. Natural products as drugs and tools for influencing core processes of eukaryotic mRNA translation.
Burgers LD; Fürst R
Pharmacol Res; 2021 Aug; 170():105535. PubMed ID: 34058326
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of eukaryotic translation elongation by the antitumor natural product Mycalamide B.
Dang Y; Schneider-Poetsch T; Eyler DE; Jewett JC; Bhat S; Rawal VH; Green R; Liu JO
RNA; 2011 Aug; 17(8):1578-88. PubMed ID: 21693620
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Evaluation of Agelastatin Derivatives as Potent Modulators for Cancer Invasion and Metastasis.
Antropow AH; Xu K; Buchsbaum RJ; Movassaghi M
J Org Chem; 2017 Aug; 82(15):7720-7731. PubMed ID: 28696693
[TBL] [Abstract][Full Text] [Related]
7. A Virtual Screening Platform Identifies Chloroethylagelastatin A as a Potential Ribosomal Inhibitor.
Caulfield TR; Hayes KE; Qiu Y; Coban M; Seok Oh J; Lane AL; Yoshimitsu T; Hazlehurst L; Copland JA; Tun HW
Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33027969
[TBL] [Abstract][Full Text] [Related]
8. New total synthesis of the marine antitumor alkaloid (-)-agelastatin A.
Domostoj MM; Irving E; Scheinmann F; Hale KJ
Org Lett; 2004 Jul; 6(15):2615-8. PubMed ID: 15255704
[TBL] [Abstract][Full Text] [Related]
9. Total synthesis of (+/-)-agelastatin A, a potent inhibitor of osteopontin-mediated neoplastic transformations.
Dickson DP; Wardrop DJ
Org Lett; 2009 Mar; 11(6):1341-4. PubMed ID: 19228041
[TBL] [Abstract][Full Text] [Related]
10. The
D'Ambrosio M
Molecules; 2023 Sep; 28(19):. PubMed ID: 37836663
[TBL] [Abstract][Full Text] [Related]
11. The Amaryllidaceae Alkaloid Haemanthamine Binds the Eukaryotic Ribosome to Repress Cancer Cell Growth.
Pellegrino S; Meyer M; Zorbas C; Bouchta SA; Saraf K; Pelly SC; Yusupova G; Evidente A; Mathieu V; Kornienko A; Lafontaine DLJ; Yusupov M
Structure; 2018 Mar; 26(3):416-425.e4. PubMed ID: 29429877
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anticancer activity of all known (-)-agelastatin alkaloids.
Han S; Siegel DS; Morrison KC; Hergenrother PJ; Movassaghi M
J Org Chem; 2013 Dec; 78(23):11970-84. PubMed ID: 24152243
[TBL] [Abstract][Full Text] [Related]
13. Eudistomin C, an Antitumor and Antiviral Natural Product, Targets 40S Ribosome and Inhibits Protein Translation.
Ota Y; Chinen T; Yoshida K; Kudo S; Nagumo Y; Shiwa Y; Yamada R; Umihara H; Iwasaki K; Masumoto H; Yokoshima S; Yoshikawa H; Fukuyama T; Kobayashi J; Usui T
Chembiochem; 2016 Sep; 17(17):1616-20. PubMed ID: 27304596
[TBL] [Abstract][Full Text] [Related]
14. Compounds, compositions, and methods of agelastatin alkaloids: patent evaluation of WO2015042239 (A1).
Yoshimitsu T; Tun HW
Expert Opin Ther Pat; 2017 Feb; 27(2):113-119. PubMed ID: 28056571
[TBL] [Abstract][Full Text] [Related]
15. Versatile Synthetic Route to Cycloheximide and Analogues That Potently Inhibit Translation Elongation.
Park Y; Koga Y; Su C; Waterbury AL; Johnny CL; Liau BB
Angew Chem Int Ed Engl; 2019 Apr; 58(16):5387-5391. PubMed ID: 30802354
[TBL] [Abstract][Full Text] [Related]
16. Natural products targeting the elongation phase of eukaryotic protein biosynthesis.
Brönstrup M; Sasse F
Nat Prod Rep; 2020 Jun; 37(6):752-762. PubMed ID: 32428051
[TBL] [Abstract][Full Text] [Related]
17. R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance.
Skripkin E; McConnell TS; DeVito J; Lawrence L; Ippolito JA; Duffy EM; Sutcliffe J; Franceschi F
Antimicrob Agents Chemother; 2008 Oct; 52(10):3550-7. PubMed ID: 18663023
[TBL] [Abstract][Full Text] [Related]
18. Agelastatin A: a novel inhibitor of osteopontin-mediated adhesion, invasion, and colony formation.
Mason CK; McFarlane S; Johnston PG; Crowe P; Erwin PJ; Domostoj MM; Campbell FC; Manaviazar S; Hale KJ; El-Tanani M
Mol Cancer Ther; 2008 Mar; 7(3):548-58. PubMed ID: 18347142
[TBL] [Abstract][Full Text] [Related]
19. Context-specific action of macrolide antibiotics on the eukaryotic ribosome.
Svetlov MS; Koller TO; Meydan S; Shankar V; Klepacki D; Polacek N; Guydosh NR; Vázquez-Laslop N; Wilson DN; Mankin AS
Nat Commun; 2021 May; 12(1):2803. PubMed ID: 33990576
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for context-specific inhibition of translation by oxazolidinone antibiotics.
Tsai K; Stojković V; Lee DJ; Young ID; Szal T; Klepacki D; Vázquez-Laslop N; Mankin AS; Fraser JS; Fujimori DG
Nat Struct Mol Biol; 2022 Feb; 29(2):162-171. PubMed ID: 35165456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
